Literature DB >> 15379835

Natural history of gastro-oesophageal reflux disease diagnosed in general practice.

A Ruigómez1, L A García Rodríguez, M-A Wallander, S Johansson, H Graffner, J Dent.   

Abstract

BACKGROUND: Cross-sectional studies indicate that gastro-oesophageal reflux disease symptoms have a prevalence of 10-20% in Western countries and are associated with obesity, smoking, oesophagitis, chest pain and respiratory disease. AIM: To determine the natural history of gastro-oesophageal reflux disease presenting in primary care in the UK.
METHODS: Patients with a first diagnosis of gastro-oesophageal reflux disease during 1996 were identified in the UK General Practice Research Database and compared with age- and sex-matched controls. We investigated the incidence of gastro-oesophageal reflux disease, potential risk factors and comorbidities, and relative risk for subsequent oesophageal complications and mortality.
RESULTS: The incidence of a gastro-oesophageal reflux disease diagnosis was 4.5 per 1000 person-years (95% confidence interval: 4.4-4.7). Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions were associated with an increased risk of gastro-oesophageal reflux disease diagnosis. Subjects with gastro-oesophageal reflux disease had an increased risk of respiratory problems, chest pain and angina in the year after diagnosis, and had a relative risk of 11.5 (95% confidence interval: 5.9-22.3) of being diagnosed with an oesophageal complication. There was an increase in mortality in the gastro-oesophageal reflux disease cohort only in the year following the diagnosis.
CONCLUSIONS: Gastro-oesophageal reflux disease is a disease associated with a range of potentially serious oesophageal complications and extra-oesophageal diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379835     DOI: 10.1111/j.1365-2036.2004.02169.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  62 in total

1.  Gastroesophageal reflux disease: Important considerations for the older patients.

Authors:  Maxwell M Chait
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

2.  Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area.

Authors:  Sushil Kumar; Saurabh Sharma; Tsering Norboo; Diskit Dolma; Angchuk Norboo; Tsering Stobdan; S Rohatgi; K Munot; Vineet Ahuja; Anoop Saraya
Journal:  Indian J Gastroenterol       Date:  2010-12-23

Review 3.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study.

Authors:  Andreas Hallan; Maria Bomme; Kristian Hveem; Jane Møller-Hansen; Eivind Ness-Jensen
Journal:  Am J Gastroenterol       Date:  2015-02-10       Impact factor: 10.864

5.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

6.  The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.

Authors:  William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-30       Impact factor: 4.254

Review 7.  Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause?

Authors:  Nigel Flook; Peter Unge; Lars Agréus; Björn W Karlson; Staffan Nilsson
Journal:  Can Fam Physician       Date:  2007-02       Impact factor: 3.275

8.  Prolapse gastropathy syndrome may be a predictor of pathologic acid reflux.

Authors:  Jin-Soo Kim; Hyung-Keun Kim; Young-Seok Cho; Hiun-Suk Chae; Byung-Wook Kim; Jin-Il Kim; Sok-Won Han; Kyu-Yong Choi
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

9.  The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study.

Authors:  John Birk; Ronald Pruitt; Gregory Haber; Isaac Raijman; Arthur Baluyut; Mick Meiselman; Shahriar Sedghi
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey.

Authors:  Frank K Friedenberg; Alexandra Hanlon; Vishwas Vanar; Dawit Nehemia; Jyothi Mekapati; Deborah B Nelson; Joel E Richter
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.